Skip to content
Side Effects

GLP-1 Side Effects: What to Expect and How to Cope

A practical guide to GLP-1 medication side effects with frequency data from clinical trials, management tips, and when to call your doctor.

Dr. Sarah Chen, PharmD Dr. Sarah Chen, PharmD | | 9 min read
Reviewed by: GLP-1 Source Editorial Team | Our editorial process

You’ve decided to start a GLP-1 medication. You’ve picked a provider, filled out the intake forms, and your first shipment is on its way. Now comes the part nobody loves talking about: side effects.

Here’s the truth. Most people experience some side effects, especially in the first few weeks. The GLP-1 clinical trials don’t hide this. Nausea hit about 44% of participants. Diarrhea affected 30%. These are real numbers from real studies.

But here’s the other truth: for most people, side effects peak early and then fade. And there are practical things you can do to make the adjustment period much more manageable.

This guide covers what to expect, how common each side effect really is, what helps, and when you should pick up the phone and call your doctor.

Common Side Effects

These are the side effects reported by 10% or more of participants in the major clinical trials (STEP 1 for semaglutide, SURMOUNT-1 for tirzepatide). They’re uncomfortable, but they’re generally not dangerous.

Nausea

How common: 44% of semaglutide patients, 44% of tirzepatide patients

Nausea is the number one side effect. It’s also the one that scares people the most. Here’s what it typically looks like:

  • Starts within the first week of a new dose
  • Worst during the first 2-3 days after each dose escalation
  • Usually mild to moderate (queasy, not vomiting)
  • Tends to improve within 4-8 weeks as your body adjusts
  • Some people barely notice it; others find it genuinely miserable for a few weeks

Management tips:

  • Eat smaller meals. Your stomach is emptying more slowly now. Large meals will make you feel worse.
  • Eat slowly. Give your brain time to register fullness signals.
  • Avoid high-fat, greasy, or fried foods. These are the hardest to digest when gastric emptying is slowed.
  • Stay upright after eating. Don’t lie down for at least 30 minutes after meals.
  • Ginger. Ginger tea, ginger chews, or ginger capsules help some people. The evidence is modest but the risk is zero.
  • Time your injection. Some people do better injecting at night so they sleep through the worst nausea. Others prefer morning. Experiment.
  • Ask about ondansetron (Zofran). If nausea is significantly affecting your quality of life, your provider can prescribe an anti-nausea medication to use during dose escalation.

Diarrhea

How common: 30% of semaglutide patients, 33% of tirzepatide patients

Diarrhea tends to be episodic rather than constant. It often shows up in the first week of a new dose and resolves as your body adjusts.

Management tips:

  • Stay hydrated. Diarrhea depletes fluids and electrolytes. Drink water and consider an electrolyte supplement.
  • Watch your fiber intake. Too much fiber can worsen diarrhea. Scale back temporarily if needed.
  • Avoid sugar alcohols. Artificial sweeteners like sorbitol and maltitol can amplify GI symptoms.
  • Probiotics. Some patients report improvement with a daily probiotic, though clinical evidence specifically for GLP-1-related diarrhea is limited.

Constipation

How common: 24% of semaglutide patients, 23% of tirzepatide patients

This one seems contradictory — how can a medication cause both diarrhea and constipation? Different people react differently. The slower gastric emptying that GLP-1 medications cause can go either direction.

Management tips:

  • Drink more water. Slowed digestion plus dehydration is a recipe for constipation. Aim for 64-80oz daily.
  • Fiber-rich foods. Fruits, vegetables, whole grains. Increase gradually to avoid bloating.
  • Movement. Even a 20-minute daily walk helps keep things moving.
  • Magnesium citrate. A gentle, over-the-counter option. Start with a low dose.
  • Stool softeners. Docusate sodium (Colace) is safe for ongoing use if needed. Ask your provider.

Vomiting

How common: 25% of semaglutide patients, 25% of tirzepatide patients

Vomiting is less common than nausea alone, and when it happens, it’s usually linked to eating too much or eating triggering foods early in treatment.

Management tips:

  • Follow all the nausea management tips above
  • Stop eating when you’re satisfied, not full. Your satiety signals are changing. The “I’m full” signal now comes earlier, and pushing past it is when vomiting happens.
  • If you vomit within 30 minutes of your injection, contact your provider about whether to re-dose. Don’t re-inject without guidance.

Abdominal Pain

How common: 14% of semaglutide patients, 14% of tirzepatide patients

Usually described as cramping or general stomach discomfort. It’s related to the GI changes the medication causes and typically resolves with the same strategies that help nausea.

When it’s concerning: Severe abdominal pain, especially radiating to your back, is different from general discomfort. That’s a pancreatitis warning sign. See the “Serious Side Effects” section below.

Headache

How common: 14% of semaglutide patients, 12% of tirzepatide patients

Headaches are common in the first few weeks and may be related to dietary changes (eating less), dehydration, or the medication itself.

Management tips:

  • Hydrate. The most common culprit is simply not drinking enough water, especially if you’re eating less.
  • Don’t skip meals. Eating less doesn’t mean eating nothing. Blood sugar drops from skipping meals can trigger headaches.
  • OTC pain relievers. Acetaminophen (Tylenol) or ibuprofen (Advil) are fine for occasional use.

Fatigue

How common: 11% of semaglutide patients, 9% of tirzepatide patients

Some people feel more tired than usual, particularly during the first 2-4 weeks of a new dose. This is likely related to caloric reduction and metabolic adjustments.

Management tips:

  • Make sure you’re eating enough. Reduced appetite is the point of the medication, but eating too little will sap your energy. Aim for at least 1,200 calories daily.
  • Protein first. Prioritize protein at every meal to maintain muscle mass and energy.
  • Sleep. This sounds obvious, but your body is undergoing metabolic changes. Give it adequate rest.

Serious but Rare Side Effects

These side effects are uncommon, but they’re serious enough that you need to know the warning signs.

Pancreatitis

How common: Less than 1% in clinical trials

Pancreatitis is inflammation of the pancreas. It’s the most commonly discussed serious risk with GLP-1 medications.

Warning signs:

  • Severe, persistent abdominal pain (often in the upper abdomen)
  • Pain that radiates to your back
  • Pain that worsens after eating
  • Nausea and vomiting that’s distinctly different from your usual GLP-1 side effects
  • Fever

What to do: Stop the medication and seek medical attention immediately. Don’t wait to see if it improves. Pancreatitis can become life-threatening if untreated.

Risk factors: History of pancreatitis, gallstones, heavy alcohol use, very high triglycerides. If you have any of these, make sure your prescribing provider knows before you start treatment.

Gallbladder Problems

How common: 1.5-2% in clinical trials (higher than the general population rate)

Rapid weight loss from any cause increases gallbladder risk. GLP-1 medications may add additional risk through their effects on bile acid metabolism.

Warning signs:

  • Sharp pain in the upper right abdomen
  • Pain after eating, especially fatty foods
  • Nausea or vomiting
  • Yellowing of the skin or eyes (jaundice)

What to do: Contact your provider. Gallbladder issues are treatable, but ignoring them can lead to complications.

Thyroid C-Cell Tumors

The context: Both semaglutide and tirzepatide carry a boxed warning about thyroid C-cell tumors based on animal studies in rodents. These tumors have not been confirmed in humans.

Who should not take GLP-1 medications:

  • People with a personal or family history of medullary thyroid carcinoma (MTC)
  • People with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

Warning signs:

  • A lump or swelling in your neck
  • Difficulty swallowing
  • Hoarseness
  • Shortness of breath

What to do: Report any of these symptoms to your provider promptly.

Hypoglycemia (Low Blood Sugar)

How common: Rare when GLP-1 medications are used alone for weight loss. More common in people also taking insulin or sulfonylureas for diabetes.

Warning signs:

  • Shakiness, sweating, dizziness
  • Confusion or difficulty concentrating
  • Rapid heartbeat
  • Intense hunger

What to do: If you feel hypoglycemic, eat or drink something with fast-acting sugar (juice, glucose tablets). If you’re not diabetic and you’re only taking a GLP-1 medication, true hypoglycemia is unlikely. But if it happens, contact your provider.

Kidney Problems

How common: Rare, but reported in patients who experienced severe dehydration from vomiting or diarrhea.

GLP-1 medications don’t directly damage the kidneys. But severe, prolonged GI symptoms that lead to dehydration can cause acute kidney injury. This is why managing GI side effects matters, and why staying hydrated is so important.

Warning signs:

  • Significantly decreased urination
  • Swelling in your legs or ankles
  • Persistent vomiting or diarrhea lasting more than 48 hours

What to do: Seek medical attention. IV fluids may be needed.

Why Dose Escalation Matters

Every GLP-1 medication uses a dose escalation protocol. You start low and increase gradually over weeks or months. Here’s why this isn’t optional:

Side effects are dose-dependent. The nausea, diarrhea, and vomiting rates in clinical trials are largely driven by the escalation phase. People who start at a low dose and increase slowly have significantly fewer and milder side effects than those who jump to higher doses.

Your GI system needs time to adapt. GLP-1 medications fundamentally change how your stomach and intestines work. Slowing gastric emptying, altering bile acid secretion, changing gut motility. Your body needs weeks to adjust to each new dose level.

Skipping ahead doesn’t help. Some people (or providers) try to accelerate the schedule to speed up weight loss. This almost always backfires. The weight loss comes at every dose level, and the severe nausea from skipping steps often causes people to quit treatment entirely.

The standard schedules:

  • Semaglutide: 0.25mg to 2.4mg over 16 weeks
  • Tirzepatide: 2.5mg to 15mg over 20 weeks

Your provider may adjust the pace based on how you respond. Some people stay at a mid-level dose longer if side effects are persistent. That’s good clinical practice, not a problem.

For a full comparison of these dosing schedules, see our semaglutide vs. tirzepatide guide.

When to Call Your Doctor

Don’t tough it out when something feels wrong. Contact your provider if:

  • Nausea or vomiting prevents you from eating or drinking for more than 24 hours. Dehydration is a real risk.
  • You have severe abdominal pain. Especially if it’s in the upper abdomen and radiates to your back (pancreatitis warning).
  • You notice a lump in your neck. Get evaluated for thyroid concerns.
  • Your eyes or skin turn yellow. Possible gallbladder or liver issue.
  • You feel lightheaded or faint. Could indicate dehydration, hypoglycemia, or other issues.
  • Side effects aren’t improving after 4-6 weeks at the same dose. Your provider may need to slow the escalation, adjust your dose, or consider switching medications.
  • You feel depressed or have mood changes. Some patients report mood effects. While not a common trial finding, it’s worth discussing with your provider.

General rule: If a side effect is affecting your ability to work, sleep, eat, or function normally, that’s worth a call. You shouldn’t be suffering through treatment.

Frequently Asked Questions

Do side effects mean the medication is working?

Not exactly. Side effects mean the medication is active in your body, which is also when it’s producing weight loss. But the severity of side effects doesn’t correlate with effectiveness. People with minimal nausea lose just as much weight as people who are miserable for weeks.

Will side effects come back when I increase my dose?

Often, yes. Each dose escalation can trigger a new round of GI symptoms, but they’re typically milder and shorter-lived than the first time. Your body is partially adapted by then.

Can I take anti-nausea medication with GLP-1 drugs?

Yes. Ondansetron (Zofran) is commonly prescribed alongside GLP-1 medications during dose escalation. Ask your provider. Over-the-counter options like meclizine or ginger supplements are also safe.

What if I miss a dose?

If you miss your scheduled injection by a day or two, take it as soon as you remember. If it’s been more than half the time until your next dose (more than 3-4 days for a weekly injection), skip it and take the next one on schedule. Don’t double up.

Do side effects differ between compounded and brand-name?

The side effects come from the molecule (semaglutide or tirzepatide), not the manufacturer. If the compounding is done correctly and the dose is accurate, you should expect the same side effect profile. Read more in our compounded vs. brand-name comparison.

How long do side effects last overall?

Most people find that GI side effects are manageable or gone by 8-12 weeks after reaching their maintenance dose. Some people adjust faster. A small percentage have persistent issues that require dose reduction or medication changes.

The Bottom Line

Side effects are the trade-off for a medication that produces 15-22% body weight loss. For most people, they’re temporary, manageable, and worth it.

The keys to getting through the adjustment period: eat smaller meals, stay hydrated, follow the dose escalation schedule, and communicate with your provider when something doesn’t feel right.

Don’t let fear of side effects stop you from starting treatment. And don’t let actual side effects stop you from talking to your provider about solutions. There’s almost always a way to manage them.

Ready to get started? Our guide to choosing a GLP-1 provider walks you through what to look for. Or browse vetted providers on our clinic comparison page, read individual reviews, and check out our head-to-head comparisons. If you’re still weighing your options between medications, check out our beginner’s guide to GLP-1 medications.

Sources & Citations

  1. [1] https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/medications-containing-semaglutide-marketed-type-2-diabetes-or-obesity
  2. [2] https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215256s007lbl.pdf
  3. [3] https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217806s000lbl.pdf
  4. [4] https://www.nejm.org/doi/full/10.1056/NEJMoa2032183
  5. [5] https://www.nejm.org/doi/full/10.1056/NEJMoa2206038

Get GLP-1 Updates

Evidence-based insights delivered weekly. No spam, unsubscribe anytime.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before making any health decisions.